Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
99 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT FLUCONAZOLE | 100MG | TABLET | Resolved | 2023-06-19 | 2023-07-21 | 195551 |
| ACT FLUCONAZOLE | 100MG | TABLET | Resolved | 2023-02-02 | 2023-10-04 | 183392 |
| ACT FLUVOXAMINE | 100MG | TABLET | Resolved | 2018-02-21 | 2019-05-28 | 40420 |
| ACT FLUVOXAMINE | 50MG | TABLET | Resolved | 2021-07-29 | 2022-04-28 | 143236 |
| ACT FLUVOXAMINE | 100MG | TABLET | Resolved | 2021-03-04 | 2022-04-21 | 135138 |
| ACT FLUVOXAMINE | 50MG | TABLET | Resolved | 2023-07-18 | 2024-03-18 | 199092 |
| ACT FLUVOXAMINE | 50MG | TABLET | Resolved | 2018-02-21 | 2019-05-28 | 40417 |
| ACT FLUVOXAMINE | 100MG | TABLET | Resolved | 2023-10-05 | 2023-10-19 | 206404 |
| ACT FLUVOXAMINE | 50MG | TABLET | Resolved | 2023-01-12 | 2023-06-09 | 180878 |
| ACT FLUVOXAMINE | 100MG | TABLET | Resolved | 2023-11-03 | 2024-05-09 | 209108 |
| ACT LATANOPROST/TIMOLOL | 5MG 50MCG | SOLUTION | Actual shortage | 2021-08-27 | 2022-08-18 | 144701 |
| ACT LATANOPROST/TIMOLOL | 50MCG 5MG | SOLUTION | Resolved | 2021-02-25 | 2021-05-20 | 134730 |
| ACT LATANOPROST/TIMOLOL | 5MG 50MCG | SOLUTION | Resolved | 2020-03-06 | 2020-03-26 | 108027 |
| ACT LATANOPROST/TIMOLOL | 5MG 50MCG | SOLUTION | Resolved | 2019-08-22 | 2019-10-24 | 92229 |
| ACT LATANOPROST/TIMOLOL | 50MCG 5MG | SOLUTION | Resolved | 2020-09-11 | 2020-12-17 | 124101 |
| ACT LEVETIRACETAM | 750MG | TABLET | Resolved | 2020-09-17 | 2020-12-17 | 124468 |
| ACT LEVETIRACETAM | 750MG | TABLET | Resolved | 2017-05-10 | 2018-10-11 | 9939 |
| ACT LEVETIRACETAM | 500MG | TABLET | Resolved | 2017-05-10 | 2018-10-11 | 9922 |
| ACT LEVETIRACETAM | 500MG | TABLET | Resolved | 2019-09-05 | 2020-01-24 | 93172 |
| ACT LEVETIRACETAM | 250MG | TABLET | Resolved | 2018-09-27 | 2018-10-12 | 62458 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PIOGLITAZONE | 15MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65026 |
| TEVA-PIOGLITAZONE | 30MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65030 |
| TEVA-PIOGLITAZONE | 45MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65033 |
| TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253171 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253174 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253177 |
| TEVA-PREDNISONE | 5MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81376 |
| TEVA-PREGABALIN | 75MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120033 |
| TEVA-PROCTOSONE | 1% 1% 0.5% 0.5% | OINTMENT | Discontinued | 2025-04-25 | 2025-04-25 | 255840 |
| TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
| TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
| TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65036 |
| TEVA-QUETIAPINE | 200MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65039 |
| TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65044 |
| TEVA-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65047 |
| TEVA-QUININE | 300MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104294 |
| TEVA-QUININE | 200MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125976 |
| TEVA-RABEPRAZOLE EC | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-07-10 | 2020-07-10 | 120015 |
| TEVA-RABEPRAZOLE EC | 10MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-07-10 | 2020-07-10 | 120018 |